{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:05:38Z","timestamp":1791223538841,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.05.100","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T14:45:16Z","timestamp":1370875516000},"page":"3644-3650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Outer membrane protein A (OmpA) from Shigella flexneri 2a: A promising subunit vaccine candidate"],"prefix":"10.1016","volume":"31","author":[{"given":"Debasis","family":"Pore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.100_bib0005","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0010","first-page":"134","article-title":"Existing status of shigellosis in Andaman. Existing status of shigellosis in Andaman & Nicobar Islands","volume":"103","author":"Ghosh","year":"1996","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/infdis\/165.1.144","article-title":"Shigella and enteroinvasive Escherichia coli infections in households of children with dysentery in Bangkok","volume":"16","author":"Echeveriia","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0020","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/oxfordjournals.aje.a116134","article-title":"Epidemiologic pattern of acute diahhroea and endemic Shigella infections in children in a poor periurban setting in Santiago","volume":"134","author":"Fereccio","year":"1991","journal-title":"Chile Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/clinids\/13.2.248","article-title":"Four decades of shigellosis in Israel \u2014 the epidemiology of a growing public health problem","volume":"13","author":"Green","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/dkg080","article-title":"Growing antimicrobial resistance of Shigella isolates","volume":"51","author":"Ashkenazi","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0264-410X(95)80017-8","article-title":"Safety and immunogenicity of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers","volume":"13","author":"Anders","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0040","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.100_bib0045","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/IAI.69.3.1351-1357.2001","article-title":"Safety and immunogenicity of improved Shigella O-specific polysaccharide\u2013protein conjugate vaccines in adults in Israel","volume":"69","author":"Passwell","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.100_bib0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/IAI.73.1.258-267.2005","article-title":"Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608 (pCFAI) and SC608 (pCFAI\/LTB) that express antigens from enterotoxigenic Escherichia coli","volume":"73","author":"Ranallo","year":"2005","journal-title":"Infect Immun"},{"issue":"18","key":"10.1016\/j.vaccine.2013.05.100_bib0055","first-page":"3728","article-title":"Immunogenicity of multivalent Shigella\u2013ETEC candidate vaccine strains in a guinea pig model","volume":"24","author":"Berry","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2013.05.100_bib0060","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2007.12.040","article-title":"Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a","volume":"26","author":"Turbyfill","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.05.100_bib0065","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/CVI.00435-08","article-title":"Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccines","volume":"16","author":"Kaminski","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.100_bib0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/JB.92.1.17-22.1966","article-title":"Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine","volume":"92","author":"Formal","year":"1966","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.05.100_bib0075","first-page":"457","article-title":"Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains","volume":"45","author":"Mel","year":"1971","journal-title":"Bull World Health Org"},{"issue":"4","key":"10.1016\/j.vaccine.2013.05.100_bib0080","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/IAI.70.4.2016-2021.2002","article-title":"Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults","volume":"70","author":"Kotloff","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2013.05.100_bib0085","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/IAI.72.2.923-930.2004","article-title":"Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers","volume":"72","author":"Katz","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0090","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/IAI.68.3.1034-1039.2000","article-title":"Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans","volume":"68","author":"Kotloff","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0095","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1016\/j.vaccine.2004.01.038","article-title":"Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies","volume":"22","author":"Peng","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0100","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1002\/pmic.200401326","article-title":"Immunoproteomics of outer membrane proteins and extracellular proteins of Shigella flexneri 2a 2457T","volume":"5","author":"Ying","year":"2005","journal-title":"Proteomics"},{"issue":"41","key":"10.1016\/j.vaccine.2013.05.100_bib0105","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.3748\/wjg.v12.i41.6683","article-title":"Immunoproteomic analysis of soluble and membrane proteins of Shigella flexneri 2a 2457T","volume":"12","author":"Jennison","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0110","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/IAI.74.5.2676-2685.2006","article-title":"Outer membrane protein A of Escherichia coli O157:H7 stimulates dendritic cell activation","volume":"74","author":"Torres","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1432-1327.1998.2550446.x","article-title":"The recombinant Klebsiella pneumoniae outer membrane protein OmpA has carrier properties for conjugated antigenic peptides","volume":"255","author":"Haeuw","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0120","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1128\/IAI.69.10.6434-6444.2001","article-title":"Targeting of nasal mucosa associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae","volume":"69","author":"Goetsch","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1078\/0171-9335-00303","article-title":"Outer membrane protein A (OmpA) activates human epidermal Langerhans cells","volume":"82","author":"Godefroy","year":"2003","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/82751","article-title":"OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway","volume":"1","author":"Jeannin","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0135","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.4049\/jimmunol.165.5.2335","article-title":"Outer membrane protein A (OmpA) binds to and activates human macrophages","volume":"165","author":"Soulas","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0140","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/immu.200310006","article-title":"Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs","volume":"33","author":"Jeannin","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0145","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0264-410X(03)00111-7","article-title":"Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition","volume":"21","author":"Mukhopadhaya","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0150","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1016\/j.vaccine.2006.03.026","article-title":"Role of Shigella flexneri 2a 34kDa outer membrane protein in induction of protective immune response","volume":"24","author":"Mukhopadhaya","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2013.05.100_bib0155","doi-asserted-by":"crossref","first-page":"e22663","DOI":"10.1371\/journal.pone.0022663","article-title":"Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model","volume":"6","author":"Pore","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.100_bib0160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4161\/hv.7.1.13351","article-title":"Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains","volume":"7","author":"Chang","year":"2011","journal-title":"Human Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2013.05.100_bib0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00239-006-0021-2","article-title":"Positively selected codons in immune-exposed loops of the vaccine candidate OMP-P1 of Haemophilus influenzae","volume":"64","author":"Mes","year":"2007","journal-title":"J Mol Evol"},{"issue":"27","key":"10.1016\/j.vaccine.2013.05.100_bib0170","doi-asserted-by":"crossref","first-page":"24825","DOI":"10.1074\/jbc.M302803200","article-title":"Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential","volume":"278","author":"Vandeputte-Rutten","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0180","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/00006454-199704001-00002","article-title":"Pertussis: current concepts of pathogenesis and prevention","volume":"16","author":"Hewlett","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0185","first-page":"1","article-title":"Structure and function of pore-forming beta-barrels from bacteria","volume":"4","author":"Delcour","year":"2002","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/JB.136.1.280-285.1978","article-title":"Cell envelope and shape of Escherichia coli: multiple mutants missing the outer membrane lipoprotein and other major outer membrane proteins","volume":"136","author":"Sonntag","year":"1978","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0195","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1128\/IAI.58.6.1691-1696.1990","article-title":"A strong antibody response to the periplasmic C-terminal domain of the OmpA protein of Escherichia coli is produced by immunization with purified OmpA or with whole E. coli or Salmonella typhimurium bacteria","volume":"58","author":"Puohiniemi","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0200","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/JB.129.3.1651-1652.1977","article-title":"Action of a major outer cell envelope membrane protein in conjugation of Escherichia coli K-12","volume":"129","author":"Schweizer","year":"1977","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0205","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.bbrc.2005.03.097","article-title":"Escherichia coli outer membrane protein A adheres to human brain microvascular endothelial cells","volume":"330","author":"Shin","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0210","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/IAI.59.7.2252-2258.1991","article-title":"Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1","volume":"59","author":"Weiser","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0215","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1172\/JCI112656","article-title":"Identification of a 16,600-dalton outer membrane protein on non-typable Haemophilus influenzae as a target for human serum bactericidal antibody","volume":"78","author":"Murphy","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0220","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1128\/IAI.60.9.3497-3503.1992","article-title":"Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa","volume":"60","author":"Hughes","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0225","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1365-2672.2007.03359.x","article-title":"The Flavobacterium psychrophilum OmpA, an outer membrane glycoprotein, induces a humoral response in rainbow trout","volume":"103","author":"Dumetz","year":"2007","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-1097(03)00619-0","article-title":"Molecular cloning and characterization of a novel leptospiral lipoprotein with OmpA domain","volume":"226","author":"Koizumi","year":"2003","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0235","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0264-410X(01)00377-2","article-title":"Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis","volume":"20","author":"Crocquet-Valdes","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0240","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1021\/pr900439j","article-title":"Identification of broad cross-protective immunogens using heterogeneous antiserum-based immunoproteomic approach","volume":"8","author":"Li","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0245","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1128\/IAI.61.6.2273-2276.1993","article-title":"Bacterial antigenic variation, host immune response, and pathogen\u2013host coevolution","volume":"61","author":"Brunham","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0250","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1128\/.61.2.136-169.1997","article-title":"Common themes in microbial pathogenicity revisited","volume":"61","author":"Finlay","year":"1997","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0255","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1016\/j.vaccine.2009.07.054","article-title":"Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a","volume":"27","author":"Pore","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0260","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis","year":"2011","journal-title":"Mucosal Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.100_bib0265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1369-5274(00)00199-5","article-title":"The role of gamma interferon in antimicrobial immunity","volume":"4","author":"Shtrichman","year":"2001","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0270","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1128\/IAI.66.4.1342-1348.1998","article-title":"An essential role for gamma interferon in innate resistance to Shigella flexneri infection","volume":"66","author":"Way","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0275","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.284.5418.1313","article-title":"Phylogenetic perspectives in innate immunity","volume":"284","author":"Hoffmann","year":"1999","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2013.05.100_bib0280","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.molimm.2010.03.001","article-title":"34kDa MOMP of Shigella flexneri promotes TLR2 mediated macrophage activation with the engagement of NF-\u03baB and p38 MAP kinase signaling","volume":"47","author":"Pore","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0285","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0290","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4049\/jimmunol.170.3.1452","article-title":"CCL28 has dual roles in mucosal immunity as a chemokine with broad spectrum antimicrobial activity","volume":"170","author":"Hieshima","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0295","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jlb.59.1.24","article-title":"Expression and regulation of chemokines in bacterial pneumonia","volume":"59","author":"Standiford","year":"1996","journal-title":"J Leukoc Biol"},{"issue":"15","key":"10.1016\/j.vaccine.2013.05.100_bib0300","doi-asserted-by":"crossref","first-page":"12589","DOI":"10.1074\/jbc.M111.335554","article-title":"Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2 dependent manner and with the involvement of IL-12 and nitric oxide (NO)","volume":"287","author":"Pore","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0305","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0952-7915(99)00052-7","article-title":"Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity","volume":"12","author":"Bogdan","year":"2000","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2013.05.100_bib0310","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2498::AID-IMMU2498>3.0.CO;2-M","article-title":"Effects of nitric oxide on the induction and differentiation of Th1 cells","volume":"29","author":"Niedbala","year":"1999","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.vaccine.2013.05.100_bib0315","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ni794","article-title":"T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells","volume":"3","author":"Afkarian","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0320","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.immuni.2009.03.013","article-title":"Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12","volume":"30","author":"Schulz","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0325","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1085536","article-title":"Toll-like receptor signalling pathways","volume":"300","author":"Barton","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.100_bib0330","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.it.2005.11.005","article-title":"Triggering TLR signaling in vaccination","volume":"2","author":"van Duin","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0335","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1016\/j.vaccine.2008.09.045","article-title":"Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond","volume":"26","author":"Lahiri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.100_bib0340","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.1016\/S0264-410X(02)00383-3","article-title":"Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies","volume":"20","author":"Pascale Jeannin","year":"2002","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13007287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13007287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T03:32:43Z","timestamp":1595907163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13007287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":68,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13007287"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.100","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outer membrane protein A (OmpA) from Shigella flexneri 2a: A promising subunit vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}